Mon, Dec 29, 2014, 4:49 AM EST - U.S. Markets open in 4 hrs 41 mins


% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • heretostayiloveinovio heretostayiloveinovio Mar 23, 2014 6:24 AM Flag

    Part of: Transcript of Inovio Pharmaceuticals Fourth Quarter 2013 Financial Results March 17, 2014

    : Okay, that’s helpful. And then specifically, moving on to cervical cancer and the
    head and neck studies that you signaled that you were interested in starting this year,
    are you waiting for the data from this cervical dysplasia study, or are there other
    observations you’ve made in previous studies, or even the blinded data you’ve seen in
    the cervical dysplasia studies that encourages these studies?

    Dr. J. Joseph Kim – President and Chief Executive Officer
    We’re very optimistic about how HPV-003 data will come out, as I said before, based
    on all the T-cells that we’ve seen from other studies and so on. We are starting the
    head and neck and advanced cancer studies during the first half of this year, even
    prior to our phase II data, as well as our prostate cancer program we’re starting with
    Roche. All of these three studies are based on our firm belief that our ability to
    generate high levels of antigen specific killer CD8 T-cells is the bottom line, and we’re
    moving ahead with that because we want to capture these markets as soon as
    possible. We’re very bullish on our capabilities to generate T-cells, and certainly
    we’re banking on that to start these studies, which would allow us to expand into a
    proof of concept study for these indications as rapidly as possible.

    : And I assume we’ll get details on the study designs for head and neck and
    cervical cancer at the time that you start the studies?
    Dr. J. Joseph Kim – President and Chief Executive Officer
    Absolutely, absolutely. And, as I said, those studies are expected to start in the
    second quarter of this year, before mid-year this year.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
9.36+0.25(+2.74%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.